AzTrials
AzTrials

Periodontal Diseases InflammationNCT07914400

Timing of Oral Hygiene Improvement Relative to Subgingival Instrumentation

A study testing Nonsurgical periodontal treatment in people with Periodontal Diseases Inflammation and Periodontal Disease, run by University of Ljubljana at 1 site in Slovenia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This single-centre, randomized split-mouth trial assessed clinical periodontal changes and acute systemic inflammatory responses when supra- and subgingival instrumentation was performed concurrently with oral hygiene instruction or after 90 days of oral hygiene reinforcement. Read more about this study

Who is it for?
Ages 18 to 75 years
What is being tested?
Nonsurgical periodontal treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteSlovenia
Study dates
1 Dec 2023to 30 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age >18;
  • generalized stage II-III, grade C periodontitis;
  • FMPS and BOP indices ≥50% at baseline;
  • ≥ 1 bleeding periodontal pocket ≥5 mm in each quadrant;
  • ability to attend six-month follow-up;
  • signed written informed consent.

Who cannot join

  • Pregnancy or breastfeeding;
  • chronic systemic disease;
  • antibiotics in preceding six months;
  • periodontal treatment in preceding 12 months;
  • current smoking or cessation within five years;
  • grade II or III furcation involvement.

Trial locations and contacts

1 site in 1 country.

Slovenia1 site
  • Dental clinic - University Medical Centre Ljubljana and Faculty of Medicine University of Ljubljana

    Ljubljana, Ljubljana, 1000

Other trials in Slovenia

About this study

Official title: Effect of Oral Hygiene Improvement Before Versus at the Time of Subgingival Instrumentation on Clinical Periodontal Outcomes and High-Sensitivity C-Reactive Protein Levels: A Randomized Split-Mouth Clinical Trial

This single-centre, randomized split-mouth trial assessed clinical periodontal changes and acute systemic inflammatory responses when supra- and subgingival instrumentation was performed concurrently with oral hygiene instruction or after 90 days of oral hygiene reinforcement. Ten adults with periodontitis participated. One upper and one lower quadrant were randomly allocated to immediate instrumentation, while remaining quadrants received oral hygiene instruction and were instrumented at day 90. Clinical outcomes were evaluated at baseline, day 90 and day 180. High-sensitivity C-reactive protein was sampled before and 24 hours after each instrumentation session.

Read the detailed description

Periodontitis is a chronic inflammatory disease characterized by the progressive destruction of tooth-supporting tissues. Effective periodontal treatment requires both adequate supragingival plaque control and professional supra- and subgingival instrumentation. Although oral hygiene improvement is an essential component of periodontal therapy, the influence of its timing relative to subgingival instrumentation on clinical treatment outcomes and the acute systemic inflammatory response remains insufficiently understood.

The aim of this single-centre, randomized, controlled, split-mouth clinical trial was to investigate whether improving oral hygiene before periodontal instrumentation, compared with initiating oral hygiene improvement at the time of instrumentation, influences clinical periodontal outcomes and the acute systemic inflammatory response, assessed by changes in serum high-sensitivity C-reactive protein (hs-CRP) concentrations 24 hours after treatment.

Ten adults diagnosed with generalized periodontitis (Stage II or III, Grade C) were enrolled at the Department of Oral Medicine and Periodontology, University Medical Centre Ljubljana, Slovenia. All participants underwent a comprehensive periodontal examination, including measurements of probing pocket depth (PPD), clinical attachment level (CAL), gingival recession, bleeding on probing (BOP), and full-mouth plaque score (FMPS). Intraoral three-dimensional scans were obtained to assess changes in gingival soft-tissue morphology.

A computer-generated randomization procedure was used to allocate one maxillary and one mandibular quadrant in each participant to immediate periodontal instrumentation. These quadrants received supra- and subgingival instrumentation at baseline, together with individualized oral hygiene instruction and motivation. The remaining two quadrants initially received oral hygiene instruction without periodontal instrumentation. Participants were instructed in appropriate toothbrushing and interdental cleaning techniques and attended follow-up appointments for plaque assessment and reinforcement of oral hygiene practices.

At day 90, a comprehensive periodontal examination and intraoral scan were repeated. The previously untreated quadrants then underwent supra- and subgingival instrumentation, following 90 days of oral hygiene improvement. Additional follow-up visits were performed 1, 7, 14, and 30 days after each instrumentation session. The final periodontal examination and intraoral scan were conducted at day 180, corresponding to 90 days after instrumentation of the second group of quadrants.

Venous blood samples were collected immediately before and 24 hours after each instrumentation session to determine serum hs-CRP concentrations. These measurements were used to assess the acute systemic inflammatory response associated with periodontal instrumentation performed at different stages of oral hygiene improvement.

Clinical periodontal outcomes included changes in PPD, CAL, BOP, and plaque scores. Additional analyses evaluated treatment responses according to baseline periodontal pocket depth and assessed three-dimensional gingival soft-tissue changes using digital surface and volumetric comparisons.

The split-mouth design enabled comparisons between treatment approaches within the same participants, thereby reducing the influence of interindividual variability. The study was designed to provide preliminary evidence regarding the influence of oral hygiene improvement before subgingival instrumentation on periodontal healing and the acute systemic inflammatory response.

The study received approval from the National Medical Ethics Committee of the Republic of Slovenia (Approval No. 0120-417/2023/3). Written informed consent was obtained from all participants.

Being tested
Nonsurgical periodontal treatment
Keywords
Periodontitis, Oral Hygiene, Subgingival Instrumentation, Non-Surgical Periodontal Therapy, High-Sensitivity C-Reactive Protein (hs-CRP), Scaling and Root Planing, Systemic Inflammation, Periodontal Treatment Outcomes, Split-Mouth Randomized Clinical Trial, Gingival Soft Tissue Changes
Medical subject headings
Periodontal Diseases, Periodontal Attachment Loss, Periodontal Pocket, Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nonsurgical periodontal treatmentProcedure or surgery

    All participants received individualized oral hygiene instructions and motivation at baseline. Supra- and subgingival instrumentation was performed in one randomly selected maxillary and one randomly selected mandibular quadrant at baseline. The remaining quadrants underwent the same instrumentation at day 90. Instrumentation was performed using ultrasonic instruments (PiezoLED, KaVo) and hand instruments (Gracey curettes, Hu-Friedy, USA).

    Full-Mouth Plaque Scores (FMPS) were assessed at follow-up visits on days 1, 7, 14, and 30 after each instrumentation session, and oral hygiene instructions were reinforced as needed to achieve an FMPS below 20% before instrumentation at day 90.

    Venous blood samples were collected immediately before and 24 hours after each instrumentation session (at baseline and day 90) to measure serum high-sensitivity C-reactive protein (hs-CRP).

    Three-dimensional (3D) intraoral scans were obtained at baseline, day 90, and day 180.

Study groups in NCT07914400
Study groupRoleWhat they receive
Nonsurgical periodontal treatmentExperimentalDetailed oral hygiene instructions followed by two stage complete oral disinfection
Receives: Procedure: Nonsurgical periodontal treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Probing pocket depth (PPD)

    Probing pocket depth measured using manual probe at 6 sites around each tooth. Unit: millimeters

    Measured: At baseline

  2. Probing pocket depth (PPD)

    Probing pocket depth measured using manual probe at 6 sites around each tooth. Unit: millimeters

    Measured: 90 days after first intervention

  3. Probing pocket depth (PPD)

    Probing pocket depth measured using manual probe at 6 sites around each tooth. Unit: millimeters

    Measured: 180 days after first intervention (90 days after second intervention)

  4. Bleeding on probing (BOP)

    Yes/No after probing pocket depth measurement 6 sites around each tooth. Unit: % (bleeding sites/all sites)

    Measured: At baseline

  5. Bleeding on probing (BOP)

    Yes/No after probing pocket depth measurement 6 sites around each tooth. Unit: % (bleeding sites/all sites)

    Measured: 90 days after first intervention

  6. Bleeding on probing (BOP)

    Yes/No after probing pocket depth measurement 6 sites around each tooth. Unit: % (bleeding sites/all sites)

    Measured: 180 days after first intervention (90 days after second intervention)

  7. Clinical attachment level (CAL)

    This is the measurement of the position of the soft tissue attachment in relation to the cemento-enamel junction (CEJ).

    Two measurements are used to calculate the CAL: the probing depth and the distance from the gingival margin to the CEJ.

    Unit: millimeters

    Measured: At baseline

  8. Clinical attachment level (CAL)

    This is the measurement of the position of the soft tissue attachment in relation to the cemento-enamel junction (CEJ).

    Two measurements are used to calculate the CAL: the probing depth and the distance from the gingival margin to the CEJ.

    Unit: millimeters

    Measured: 90 days after first intervention

  9. Clinical attachment level (CAL)

    This is the measurement of the position of the soft tissue attachment in relation to the cemento-enamel junction (CEJ).

    Two measurements are used to calculate the CAL: the probing depth and the distance from the gingival margin to the CEJ.

    Unit: millimeters

    Measured: 180 days after first intervention (90 days after second intervention)

  10. Plaque index (PI)

    Yes/No at six sites around each tooth. Unit: % (sites with plaque/all sites)

    Measured: At baseline

  11. Plaque index (PI)

    Yes/No at six sites around each tooth. Unit: % (sites with plaque/all sites)

    Measured: 90 days after first intervention

  12. Plaque index (PI)

    Yes/No at six sites around each tooth. Unit: % (sites with plaque/all sites)

    Measured: 180 days after first intervention (90 days after second intervention)

Secondary outcomes (6)
  1. Change in serum hs-CRP from pre-instrumentation to 24 hours after

    The absolute change in hs-CRP concentration (24-hour post-instrumentation value minus the pre-instrumentation value), expressed in mg/L.

    Measured: Immediately before and 24 hours after baseline instrumentation

  2. Change in serum hs-CRP from pre-instrumentation to 24 hours after

    The absolute change in hs-CRP concentration (24-hour post-instrumentation value minus the pre-instrumentation value), expressed in mg/L.

    Measured: Immediately before and 24 hours after instrumentation at day 90

  3. Digital gingival surface area (mm²) deviations

    Digital models were superimposed to evaluate gingival surface deviations over time. Changes in gingival surface area were quantified in square millimetres (mm²) and compared between quadrants

    Measured: 90 days after first intervention

  4. Digital gingival surface area (mm²) deviations

    Digital models were superimposed to evaluate gingival surface deviations over time. Changes in gingival surface area were quantified in square millimetres (mm²) and compared between quadrants

    Measured: 180 days after first intervention

  5. Digital gingival volume (mm³) deviations

    Digital models were superimposed to evaluate gingival surface deviations over time. Changes in gingival volume were quantified in cubic millimetres (mm³) and compared between quadrants

    Measured: 90 days after first intervention

  6. Digital gingival volume (mm³) deviations

    Digital models were superimposed to evaluate gingival surface deviations over time. Changes in gingival volume were quantified in cubic millimetres (mm³) and compared between quadrants

    Measured: 180 days after first intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Nov 2026
  2. Study start1 Dec 2023
  3. Primary completion1 Dec 2024
  4. Study completion30 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Split-Mouth Randomized Prospective Clinical Trial
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07914400
Sponsor's protocol ID
OH and Periodontal Treatment
Status last verified
Oct 2026
First submitted
23 Oct 2026
Last updated
3 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: All Research data will be available or shared on individual request. Example: conducting Meta-Analysis.

Publications

  • Westfelt E, Rylander H, Dahlen G, Lindhe J. The effect of supragingival plaque control on the progression of advanced periodontal disease. J Clin Periodontol. 1998 Jul;25(7):536-41. doi: 10.1111/j.1600-051x.1998.tb02484.x.

    PubMed 9696252
  • Lindhe J, Nyman S. The effect of plaque control and surgical pocket elimination on the establishment and maintenance of periodontal health. A longitudinal study of periodontal therapy in cases of advanced disease. J Clin Periodontol. 1975 Apr;2(2):67-79. doi: 10.1111/j.1600-051x.1975.tb01727.x.

    PubMed 1055729
  • Cercek JF, Kiger RD, Garrett S, Egelberg J. Relative effects of plaque control and instrumentation on the clinical parameters of human periodontal disease. J Clin Periodontol. 1983 Jan;10(1):46-56. doi: 10.1111/j.1600-051x.1983.tb01266.x.

    PubMed 6572634
  • Graziani F, Gennai S, Marruganti C, Peric M, Ghiadoni L, Marhl U, Petrini M. Acute-phase response following one-stage full-mouth versus quadrant non-surgical periodontal treatment in subjects with comorbid type 2 diabetes: A randomized clinical trial. J Clin Periodontol. 2023 Apr;50(4):487-499. doi: 10.1111/jcpe.13760. Epub 2023 Jan 22.

    PubMed 36517997
  • Paterno Holtzman L, Valente NA, Vittorini Orgeas G, Copes L, Discepoli N, Clementini M. Change in clinical parameters after subgingival instrumentation for the treatment of periodontitis and timing of periodontal re-evaluation: A systematic review and meta-analysis. J Clin Periodontol. 2025 Jan;52(1):137-158. doi: 10.1111/jcpe.13985. Epub 2024 May 5.

    PubMed 38706227
  • Herrera D, Berglundh T, Schwarz F, Chapple I, Jepsen S, Sculean A, Kebschull M, Papapanou PN, Tonetti MS, Sanz M; EFP workshop participants and methodological consultant. Prevention and treatment of peri-implant diseases-The EFP S3 level clinical practice guideline. J Clin Periodontol. 2023 Jun;50 Suppl 26:4-76. doi: 10.1111/jcpe.13823. Epub 2023 Jun 4.

    PubMed 37271498

Questions about this trial

What is this clinical trial studying?

A study testing Nonsurgical periodontal treatment in people with Periodontal Diseases Inflammation and Periodontal Disease, run by University of Ljubljana at 1 site in Slovenia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Slovenia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Probing pocket depth (PPD) (time frame: At baseline). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07914400, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in